Stay updated on Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.

Latest updates to the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record for BI 695502 versus Avastin with chemotherapy is displayed, including its completed status, eligibility criteria, locations, study design, and reported outcomes.SummaryDifference100%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide notice announces updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation with an access-denied message. This indicates that the study details are currently unavailable on the site.SummaryDifference16%

Stay in the know with updates to Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison BI 695502 vs. Avastin® in Lung Cancer Clinical Trial page.